Severe refractory COVID-19 patients responding to convalescent plasma; A case series

HM Abdullah, HH Hama-Ali, SN Ahmed… - Annals of medicine …, 2020 - journals.lww.com
Conclusion: CP might be an effective therapy for severe COVID-19 patients. HIGHLIGHTS
Currently, no specific antiviral drug has been approved to target novel coronavirus.
Convalescent plasma is a classical immunotherapy. It has been used in the management of
several infectious diseases for many decades. In this report two severe cases of COVID-
2019 have been described receiving CP. 1. Introduction In the last few months, a disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), called COVID …